1-12 of 12
David J. McConkey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P174: YAP1 drives immune suppression in urothelial carcinoma of bladder

Pritam Sadhukhan, Mingxiao Feng, Emily Illingworth, Ido Sloma, M. Talha Ugurlu, Fenna Sille, Woonyoung Choi, David J. McConkey, Mohammad Hoque
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P174.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P174
Published: 01 December 2021
View article
Journal Articles

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

Kilian M. Gust, David J. McConkey, Shannon Awrey, Paul K. Hegarty, Jing Qing, Jolanta Bondaruk, Avi Ashkenazi, Bogdan Czerniak, Colin P. Dinney, Peter C. Black
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (7): 1245–1254.
DOI: https://doi.org/10.1158/1535-7163.MCT-12-1150
Published: 07 July 2013
View article
PDF
Journal Articles

Abstract B70: Histone deacetylase inhibitors reverse EMT phenotype and chemoresistance in pancreatic cancer cell lines

Keith Fournier, Woonyoung Choi, Lauren Maarquis, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B70.
DOI: https://doi.org/10.1158/1535-7163.TARG-09-B70
Published: 10 December 2009
View article
Journal Articles

Molecular correlates of gefitinib responsiveness in human bladder cancer cells

Marissa Shrader, Maria Simona Pino, Gordon Brown, Peter Black, Liana Adam, Menahse Bar-Eli, Colin P.N. Dinney, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (1): 277–285.
DOI: https://doi.org/10.1158/1535-7163.MCT-06-0513
Published: 19 January 2007
View article
PDF
Journal Articles

Combination therapy with IFN-α plus bortezomib induces apoptosis and inhibits angiogenesis in human bladder cancer cells

Angela Papageorgiou, Ashish Kamat, William F. Benedict, Colin Dinney, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (12): 3032–3041.
DOI: https://doi.org/10.1158/1535-7163.MCT-05-0474
Published: 15 December 2006
View article
PDF
Journal Articles

Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells

Sanaz Khanbolooki, Steffan T. Nawrocki, Thiruvengadam Arumugam, Robert Andtbacka, Maria S. Pino, Razelle Kurzrock, Craig D. Logsdon, James L. Abbruzzese, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (9): 2251–2260.
DOI: https://doi.org/10.1158/1535-7163.MCT-06-0075
Published: 19 September 2006
View article
PDF
Journal Articles

Bortezomib inhibits docetaxel-induced apoptosis via a p21-dependent mechanism in human prostate cancer cells

Steven E. Canfield, Keyi Zhu, Simon A. Williams, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (8): 2043–2050.
DOI: https://doi.org/10.1158/1535-7163.MCT-05-0437
Published: 23 August 2006
View article
PDF
Journal Articles

The proteasome inhibitor bortezomib synergizes with gemcitabine to block the growth of human 253JB-V bladder tumors in vivo

Ashish M. Kamat, Takashi Karashima, Darren W. Davis, Laura Lashinger, Menashe Bar-Eli, Randall Millikan, Yu Shen, Colin P. N. Dinney, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (3): 279–290.
DOI: https://doi.org/10.1158/1535-7163.279.3.3
Published: 16 March 2004
View article
PDF
Journal Articles

The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts

Steffan T. Nawrocki, Bridget Sweeney-Gotsch, Ryan Takamori, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (1): 59–70.
DOI: https://doi.org/10.1158/1535-7163.59.3.1
Published: 28 January 2004
View article
PDF
Journal Articles

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts

Simon Williams, Curtis Pettaway, Rendu Song, Christos Papandreou, Christopher Logothetis, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (9): 835–843.
Published: 10 October 2003
View article
PDF
Journal Articles

Effects of the Proteasome Inhibitor PS-341 on Apoptosis and Angiogenesis in Orthotopic Human Pancreatic Tumor Xenografts

Steffan T. Nawrocki, Christiane J. Bruns, Matthew T. Harbison, Richard J. Bold, Bridget Sweeney Gotsch, James L. Abbruzzese, Peter Elliott, Julian Adams, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (14): 1243–1253.
Published: 01 December 2002
View article
PDF
Journal Articles

Inhibition of the Phosphatidylinositol 3′-Kinase-AKT Pathway Induces Apoptosis in Pancreatic Carcinoma Cells in Vitro and in Vivo

Victor M. Bondar, Bridget Sweeney-Gotsch, Michael Andreeff, Gordon B. Mills, David J. McConkey
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (12): 989–997.
Published: 01 October 2002
View article
PDF